The Effect of β-Adrenergic Receptor Blocking Agents on Drug-Induced Insulin Secretion

Early Diabetes ◽

10.1016/b978-0-12-027361-4.50016-8 ◽

1970 ◽

pp. 87-94 ◽

Author(s):

Rubin Bressler ◽

Mario Vargas Cordon

Keyword(s):

Insulin Secretion ◽

Adrenergic Receptor ◽

Drug Induced ◽

Receptor Blocking ◽

Blocking Agents

Download Full-text

Prediction of Therapeutic Doses of Beta-Adrenergic Receptor Blocking Agents Based on Quantitative Structure-Pharmacokinetic/Pharmacodynamic Relationship.

Biological and Pharmaceutical Bulletin ◽

10.1248/bpb.16.1251 ◽

1993 ◽

Vol 16 (12) ◽

pp. 1251-1259 ◽

Author(s):

Yasuhiko YAMADA ◽

Kiyomi ITO ◽

Kouichi NAKAMURA ◽

Yasufumi SAWADA ◽

Tatsuji IGA

Keyword(s):

Adrenergic Receptor ◽

Quantitative Structure ◽

Beta Adrenergic Receptor ◽

Beta Adrenergic ◽

Receptor Blocking ◽

Blocking Agents ◽

Therapeutic Doses

Download Full-text

Mechanism of action of adrenergic receptor blocking agents in angina pectoris: Comparison of action of propranolol with dexpropranolol and practolol

BMJ ◽

10.1136/bmj.4.5680.399 ◽

1969 ◽

Vol 4 (5680) ◽

pp. 399-401 ◽

Author(s):

A. G. Wilson ◽

O. G. Brooke ◽

H. J. Lloyd ◽

B. F. Robinson

Keyword(s):

Angina Pectoris ◽

Mechanism Of Action ◽

Adrenergic Receptor ◽

Receptor Blocking ◽

Blocking Agents

Download Full-text

Ultra-short-acting .beta.-adrenergic receptor blocking agents. 3. Ethylenediamine derivatives of (aryloxy)propanolamines having esters on the aryl function

Journal of Medicinal Chemistry ◽

10.1021/jm00362a004 ◽

1983 ◽

Vol 26 (8) ◽

pp. 1109-1112 ◽

Author(s):

Paul W. Erhardt ◽

Chi M. Woo ◽

William L. Matier ◽

Richard J. Gorczynski ◽

William G. Anderson

Keyword(s):

Adrenergic Receptor ◽

Beta Adrenergic Receptor ◽

Beta Adrenergic ◽

Receptor Blocking ◽

Short Acting ◽

Blocking Agents ◽

Derivatives Of ◽

Ethylenediamine Derivatives

Download Full-text

ChemInform Abstract: ULTRA-SHORT-ACTING β-ADRENERGIC RECEPTOR BLOCKING AGENTS. 2. (ARYLOXY)PROPANOLAMINES CONTAINING ESTERS ON THE ARYL FUNCTION

Chemischer Informationsdienst ◽

10.1002/chin.198321183 ◽

1983 ◽

Vol 14 (21) ◽

Author(s):

P. W. ERHARDT ◽

C. M. WOO ◽

W. G. ANDERSON ◽

R. J. GORCZYNSKI

Keyword(s):

Adrenergic Receptor ◽

Receptor Blocking ◽

Short Acting ◽

Blocking Agents

Download Full-text

Ultra-short-acting .beta.-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent

Journal of Medicinal Chemistry ◽

10.1021/jm00354a002 ◽

1982 ◽

Vol 25 (12) ◽

pp. 1402-1407 ◽

Author(s):

Paul W. Erhardt ◽

Chi M. Woo ◽

Richard J. Gorczynski ◽

William G. Anderson

Keyword(s):

Adrenergic Receptor ◽

Beta Adrenergic Receptor ◽

Beta Adrenergic ◽

Receptor Blocking ◽

Short Acting ◽

Blocking Agents

Download Full-text

Interaction of α- and β-Adrenergic Receptor Blocking Agents in the Conscious Rat

Clinical and Experimental Hypertension ◽

10.3109/10641967909068634 ◽

1979 ◽

Vol 1 (6) ◽

pp. 709-711

Author(s):

C. Gomes ◽

G. Trolin

Keyword(s):

Adrenergic Receptor ◽

Conscious Rat ◽

Receptor Blocking ◽

Blocking Agents

Download Full-text

Role of beta-adrenergic receptor blocking agents in hypertensive diseases: personal thoughts as the controversy persists

Therapeutic Advances in Cardiovascular Disease ◽

10.1177/1753944709346519 ◽

2009 ◽

Vol 3 (6) ◽

pp. 455-464 ◽

Author(s):

Edward D. Frohlich

Keyword(s):

Adrenergic Receptor ◽

Beta Adrenergic Receptor ◽

Beta Adrenergic ◽

Receptor Blocking ◽

Blocking Agents ◽

Hypertensive Diseases

Download Full-text

Antifibrillatory Effect of Some β-Adrenergic Receptor Blocking Agents Determined by a New Test Procedure in Mice

Acta Pharmacologica et Toxicologica ◽

10.1111/j.1600-0773.1969.tb00525.x ◽

2009 ◽

Vol 28 (1) ◽

pp. 17-27 ◽

Author(s):

Keld Hermansen

Keyword(s):

Adrenergic Receptor ◽

Test Procedure ◽

Receptor Blocking ◽

Blocking Agents

Download Full-text

ChemInform Abstract: ULTRA-SHORT-ACTING β-ADRENERGIC RECEPTOR BLOCKING AGENTS. 1. (ARYLOXY)PROPANOLAMINES CONTAINING ESTERS IN THE NITROGEN SUBSTITUENT

Chemischer Informationsdienst ◽

10.1002/chin.198321169 ◽

1983 ◽

Vol 14 (21) ◽

Author(s):

P. W. ERHARDT ◽

C. M. WOO ◽

R. J. GORCZYNSKI ◽

W. G. ANDERSON

Keyword(s):

Adrenergic Receptor ◽

Receptor Blocking ◽

Short Acting ◽

Blocking Agents

Download Full-text

Oxprenolol and practolol: new beta blockers

Drug and Therapeutics Bulletin ◽

10.1136/dtb.9.1.1 ◽

1971 ◽

Vol 9 (1) ◽

pp. 1-3

Keyword(s):

Heart Failure ◽

Adrenergic Receptor ◽

Beta Blockers ◽

Pharmacological Properties ◽

Clinical Use ◽

Receptor Blocking ◽

Blocking Agents

Since the introduction of propranolol (Inderal -ICI) two more β -adrenergic receptor blocking agents have become available for clinical use, practolol (Eraldin - ICI) and oxprenolol (Trasicor - Ciba). Both manufacturers claim that their product is less likely than propranolol to precipitate heart failure or asthma. All three drugs, although structurally similar, have different pharmacological properties which are summarised in the table. The use of the drugs in different clinical situations must therefore be considered separately.

Download Full-text